MARKET

CYRX

CYRX

Cryoport
NASDAQ

Real-time Quotes | Nasdaq Last Sale

69.25
+1.88
+2.79%
Closed 16:49 09/23 EDT
OPEN
67.14
PREV CLOSE
67.37
HIGH
69.47
LOW
67.14
VOLUME
182.64K
TURNOVER
--
52 WEEK HIGH
84.97
52 WEEK LOW
39.10
MARKET CAP
3.19B
P/E (TTM)
-35.6812
1D
5D
1M
3M
1Y
5Y
Notable Cryoport Insider Trades $2.00 Million In Company Stock
Richard J Berman, Director at Cryoport (NASDAQ:CYRX), made a large buy and sell of company shares on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Richard J Berman p...
Benzinga · 09/16 15:23
Insider Sell: Cryoport
MT Newswires · 09/16 08:06
CNBC PRO Talks: Star small-cap manager Amy Zhang unveils her top stock picks
Amy Zhang, portfolio manager of the Alger Small Cap Focus, Small Cap Growth and Mid Cap Focus strategies and Mid Cap 40 ETF, joins CNBC's Brian Sullivan to discuss the state of the small and mid-cap market, and the rationale for some of her top picks.
CNBC.com · 09/01 19:49
Return on Capital Employed Overview: CryoPort
After pulling data from Benzinga Pro it seems like during Q2, CryoPort (NASDAQ:CYRX) brought in sales totaling $56.19 million. However, earnings decreased 228.2%, resulting in a loss of $3.75 million.
Benzinga · 08/31 15:37
Cryoport, Mitsubishi Logistics Partner For Temperature-Controlled Supply Chain Solutions
Benzinga · 08/25 17:24
BRIEF-Cryoport And Mitsubishi Logistics Corp Partner To Bring Temperature-Controlled Supply Chain Solutions To Asia-Pacific
reuters.com · 08/25 12:29
Cryoport, Mitsubishi Logistics Corporation Partner To Bring Temperature-Controlled Supply Chain Solutions To Asia-Pacific
- Cryoport, Inc. (NASDAQ:CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical
 Cryoport, Inc. (NASDAQ:CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical · 08/25 12:20
Cryoport, Mitsubishi Logistics Corp. Join Forces to Develop Supply Chain Solutions
MT Newswires · 08/25 10:08
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CYRX. Analyze the recent business situations of Cryoport through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CYRX stock price target is 78.50 with a high estimate of 88.00 and a low estimate of 75.00.
EPS
Institutional Holdings
Institutions: 257
Institutional Holdings: 49.44M
% Owned: 107.43%
Shares Outstanding: 46.02M
TypeInstitutionsShares
Increased
74
2.66M
New
29
346.73K
Decreased
79
2.74M
Sold Out
26
699.98K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Courier, Postal, Air Freight & Land-based Logistics
+0.75%
Freight & Logistics Services
+1.17%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jerrell Shelton
Chief Financial Officer/Treasurer
Robert Stefanovich
Senior Vice President/Chief Scientific Officer
Mark Sawicki
Lead Director/Independent Director
Richard Berman
Independent Director
Linda Baddour
Independent Director
Daniel Hancock
Independent Director
Robert Hariri
Independent Director
Ram Jagannath
Independent Director
Ramkumar Mandalam
Independent Director
Edward Zecchini
No Data
About CYRX
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services, the Company enables its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. The Company’s subsidiaries include Cryoport Systems, Inc., MVE Biological Solutions, CRYOPDP and Cryogene Partners.

Webull offers kinds of CryoPort Inc stock information, including NASDAQ:CYRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYRX stock methods without spending real money on the virtual paper trading platform.